Interleukin enhancer-binding factor 3 (ILF3) (AA 302-351) antibody
Quick Overview for Interleukin enhancer-binding factor 3 (ILF3) (AA 302-351) antibody (ABIN2879491)
Target
See all Interleukin enhancer-binding factor 3 (ILF3) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 302-351
-
Brand
- IHC-plus™
-
Specificity
- NF90 antibody detects endogenous levels of NF90.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human NF90 (aa302-351).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: IHC, IHC-P (1:50), Peptide-ELISA (1:10000), WB (1:500 - 1:1000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C.
-
-
- Interleukin enhancer-binding factor 3 (ILF3)
-
Alternative Name
- NF90 / ILF3
-
Background
-
Name/Gene ID: ILF3
Synonyms: ILF3, CBTF, DRBF, DRBP76, MMP4, NF-AT-90, NF90, NFAR2, Nuclear factor nf90, M-phase phosphoprotein 4, TCP110, MPHOSPH4, NF110b, NF90a, NF90b, NFAR-1, TCP80, NF110, NFAR -
Gene ID
- 3609
-
Pathways
- M Phase
Target
-